Gastric antral vascular ectasia (GAVE) and hereditary hemorrhagic telangiectasia (HHT): two different conditions, one treatment

Ann Hematol. 2020 Feb;99(2):367-369. doi: 10.1007/s00277-019-03845-1. Epub 2019 Nov 26.

Authors

Sara Santos¹, Carlos Bernardes², Verónica Borges², Gonçalo Ramos²

Affiliations

¹ Centro Hospitalar de Lisboa Central, Lisbon, Portugal. saramendezleiria@hotmail.com.
² Centro Hospitalar de Lisboa Central, Lisbon, Portugal.

PMID: 31773212
DOI: 10.1007/s00277-019-03845-1

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Angiogenesis Inhibitors / therapeutic use*
Argon Plasma Coagulation
Bevacizumab / therapeutic use*
Combined Modality Therapy
Erythrocyte Transfusion
Fatigue / etiology
Gastric Antral Vascular Ectasia / complications
Gastric Antral Vascular Ectasia / drug therapy*
Gastric Antral Vascular Ectasia / therapy
Glomerulonephritis, Membranoproliferative / complications
Glomerulonephritis, Membranoproliferative / therapy
Humans
Male
Melena / etiology
Middle Aged
Remission Induction
Renal Dialysis
Telangiectasia, Hereditary Hemorrhagic / drug therapy*
Thalidomide / therapeutic use

Substances

Angiogenesis Inhibitors
Bevacizumab
Thalidomide